Quick Answer
CATALYST PHARMACEUTICALS, INC. reported Common Stock Shares Outstanding of 122.51 million shares for the year ending 2025.
- CATALYST PHARMACEUTICALS, INC. showed an increase of +1.4% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from CATALYST PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: 21.65 million shares | Q3 2011: 21.65 million shares | Q1 2012: 24.74 million shares | Q2 2012: 30.74 million shares | Q3 2012: 34.74 million shares | Q1 2013: 41.42 million shares | Q2 2013: 41.47 million shares | Q3 2013: 53.99 million shares | Q1 2014: 54.15 million shares | Q2 2014: 67.17 million shares | Q3 2014: 67.17 million shares | Q1 2015: 82.01 million shares | Q2 2015: 82.10 million shares | Q3 2015: 82.70 million shares | Q1 2016: 82.87 million shares | Q2 2016: 82.87 million shares | Q3 2016: 82.87 million shares | Q1 2017: 82.97 million shares | Q2 2017: 84.55 million shares | Q3 2017: 85.23 million shares | Q1 2018: 102.59 million shares | Q2 2018: 102.60 million shares | Q3 2018: 102.69 million shares | Q1 2019: 102.80 million shares | Q2 2019: 102.93 million shares | Q3 2019: 103.04 million shares | Q1 2020: 103.41 million shares | Q2 2020: 103.42 million shares | Q3 2020: 103.65 million shares | Q1 2021: 103.80 million shares | Q2 2021: 103.16 million shares | Q3 2021: 103.15 million shares | Q1 2022: 102.96 million shares | Q2 2022: 102.71 million shares | Q3 2022: 104.06 million shares | Q1 2023: 105.94 million shares | Q2 2023: 106.50 million shares | Q3 2023: 106.61 million shares | Q1 2024: 118.03 million shares | Q2 2024: 118.52 million shares | Q3 2024: 119.27 million shares | Q1 2025: 121.96 million shares | Q2 2025: 122.39 million shares | Q3 2025: 123.26 million shares.
- Over the full 16 years of available data (2010 to 2025), CATALYST PHARMACEUTICALS, INC.'s Common Stock Shares Outstanding has grown by 531.7%.
- Historical annual values: Fiscal year 2025: 122.51 million shares | Fiscal year 2024: 120.88 million shares | Fiscal year 2023: 107.12 million shares | Fiscal year 2022: 105.26 million shares | Fiscal year 2021: 102.99 million shares | Fiscal year 2020: 103.78 million shares | Fiscal year 2019: 103.40 million shares | Fiscal year 2018: 102.74 million shares | Fiscal year 2017: 102.55 million shares | Fiscal year 2016: 82.97 million shares | Fiscal year 2015: 82.85 million shares | Fiscal year 2014: 69.12 million shares | Fiscal year 2013: 54.13 million shares | Fiscal year 2012: 41.42 million shares | Fiscal year 2011: 24.70 million shares | Fiscal year 2010: 19.39 million shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: